
Orion Investor Relations Material
Latest events

Q3 2024
Orion
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Orion Oyj
Access all reports
Orion's Pharmaceuticals business area develops, produces and markets pharmaceuticals for various indications; provides specialized dietary products and enteral feeds for the needs of healthcare, including clinical nutrition services; manufactures APIs; and offers contract manufacturing, research and development (R&D), technical development services in the field of chemistry and biochemistry, as well as develops and commercializes patient monitoring and self-monitoring products. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.
Key slides for Orion Oyj
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
ORNBV
Country
🇫🇮 Finland